Emergent Biosolutions Inc. diskutieren
Emergent Biosolutions Inc.
WKN: A0LC2W / Symbol: EBS / Name: Emergent Bio / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
7,00 €
-2,82 %
Emergent Biosolutions (NYSE:EBS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for EBS provided by MarketBeat
Emergent Biosolutions (EBS) had its "buy" rating reaffirmed by UBS Group AG.
Ratings data for EBS provided by MarketBeat
Emergent Biosolutions (EBS) had its "buy" rating reaffirmed by Benchmark Co..
Ratings data for EBS provided by MarketBeat


Neueste Beiträge
StockNews_com in China Telecom Corp. Ltd. ADR diskutieren